The analysis was a retrospective review of their urologic oncology database and 1,751 consecutive patients who underwent surgery from 2000 to 2007 included in the analysis. 519 of them underwent robotic-assisted laparoscopic prostatectomy . Clinical, pathological and risk variables were assessed in this group and compared with the open RP cohort from 2000-2002 to determine if it. Extending the patient pool with surgery after the introduction of RALP.. The study hypothesis was that with the advent of MIS more patients could choose to purchased purchased would undergo surgery in the pre – MIS time.
Did you know? – About 500 million people worldwide are currently infected with hepatitis B or C1 – This is more than 10 times the number infected with HIV/AIDS2 – Between them, hepatitis B and C kill one million people a year1 – One on three persons planet exposed to one or both viruses have been – most of the 500 million people infected do not know.The Emerging Technology Centers, Tenth St. Is a life sciences business incubator owned and operated by at Indiana University Research and Technology Inc. . The IURTC , which offer to technology transfer supporting IU School has commissioned an ownership interest in the EndGenitor position of.
Has on works with a the Indiana University Research & Technology Corp. And BioCrossroads, Mervin C. Yoder Jr. And David A. Ingram Jr. EndGenitor Technologies Inc. The begin operations 1 February. At which Emerging Technology Centre at in downtown Indianapolis.